NCT03898024View on ClinicalTrials.gov

Effects of SHR-1222 on Vascular Inflammatory Factors in Patients With Low Bone Mass

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

July 27, 2020

Study Completion Date

August 15, 2020

Conditions
Osteoporosis, Osteopenia
Interventions
DRUG

SHR-1222

Pharmaceutical form: water injection; Route of administration: subcutaneous

DRUG

Placebo

Pharmaceutical form: water injection; Route of administration: subcutaneous

Trial Locations (1)

410011

The Second Xiangya Hospital of Central South University, Changsha

All Listed Sponsors
lead

Second Xiangya Hospital of Central South University

OTHER

NCT03898024 - Effects of SHR-1222 on Vascular Inflammatory Factors in Patients With Low Bone Mass | Biotech Hunter | Biotech Hunter